Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $79.67 | 3 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $33.78 | 1 | $0 (2023) |
| Welch Allyn | $26.77 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $19.12 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $33.78 | 1 | Astellas Pharma US Inc ($33.78) |
| 2019 | $19.12 | 1 | Novartis Pharmaceuticals Corporation ($19.12) |
| 2018 | $26.77 | 1 | Welch Allyn ($26.77) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/06/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $33.78 | General |
| 03/12/2019 | Novartis Pharmaceuticals Corporation | DUREZOL (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/02/2018 | Welch Allyn | Otoscope (Device) | Food and Beverage | In-kind items and services | $26.77 | General |
| Category: Diagnostic Instruments | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 2,636 | 6,657 | $982,085 | $341,063 |
| 2022 | 21 | 2,881 | 6,500 | $1.0M | $393,517 |
| 2021 | 22 | 2,482 | 5,044 | $867,704 | $317,216 |
| 2020 | 14 | 2,416 | 4,488 | $669,067 | $248,871 |
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 767 | 1,426 | $196,788 | $83,241 | 42.3% |
| 92134 | Imaging of retina | Office | 2023 | 802 | 2,023 | $202,300 | $54,713 | 27.0% |
| 67028 | Injection of drug into eye | Office | 2023 | 214 | 561 | $168,192 | $45,805 | 27.2% |
| J3590 | Unclassified biologics | Office | 2023 | 207 | 558 | $47,685 | $25,414 | 53.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 174 | 266 | $52,402 | $23,106 | 44.1% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 36 | 750 | $50,183 | $21,839 | 43.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 141 | 141 | $39,621 | $15,024 | 37.9% |
| 67041 | Removal of membrane of retina | Facility | 2023 | 16 | 16 | $41,504 | $12,843 | 30.9% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 37 | 319 | $28,391 | $11,017 | 38.8% |
| 67113 | Complex repair of detached retina and drainage of eye fluid between lens and retina | Facility | 2023 | 11 | 11 | $36,168 | $9,840 | 27.2% |
| 67121 | Removal of implant material from inside of eye | Facility | 2023 | 14 | 15 | $25,185 | $9,534 | 37.9% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 31 | 242 | $26,862 | $8,105 | 30.2% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2023 | 12 | 13 | $31,356 | $7,604 | 24.3% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 59 | 61 | $11,224 | $5,911 | 52.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 24 | $6,600 | $2,516 | 38.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $5,776 | $1,699 | 29.4% |
| 67515 | Injection of drug or substance into membrane covering eyeball | Office | 2023 | 26 | 37 | $5,180 | $1,367 | 26.4% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 14 | 19 | $2,413 | $682.19 | 28.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $2,035 | $680.88 | 33.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 26 | 148 | $2,220 | $122.18 | 5.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 751 | 1,315 | $181,517 | $80,466 | 44.3% |
| 92134 | Imaging of retina | Office | 2022 | 805 | 1,916 | $191,600 | $53,719 | 28.0% |
| 67028 | Injection of drug into eye | Office | 2022 | 233 | 605 | $179,288 | $49,768 | 27.8% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 20 | 53 | $47,000 | $34,374 | 73.1% |
| J3590 | Unclassified biologics | Office | 2022 | 221 | 558 | $50,345 | $27,616 | 54.9% |
About Dr. John Rosenthal, M.D
Dr. John Rosenthal, M.D is a Ophthalmology healthcare provider based in Maumee, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710959549.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Rosenthal, M.D has received a total of $79.67 in payments from pharmaceutical and medical device companies, with $33.78 received in 2023. These payments were reported across 3 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($79.67).
As a Medicare-enrolled provider, Rosenthal has provided services to 10,415 Medicare beneficiaries, totaling 22,689 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist
- Location Maumee, OH
- Active Since 02/06/2006
- Last Updated 03/25/2020
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1710959549
Products in Payments
- Otoscope (Device) $26.77
- DUREZOL (Drug) $19.12
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.